In addition, some studies have shown that β2-microglobulin correlates with tumor burden, disease stage and prognosis in CLL, abnormalities in the secretion of plasma proteins such as IL-10 and TNF-α may be involved in the immune regulation of the tumor microenvironment and thereby tumor cell proliferation and affect survival. This evidence concerns the gene IL10 and neoplasm.